SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-17-027946
Filing Date
2017-04-28
Accepted
2017-04-28 16:39:10
Documents
5
Period of Report
2017-06-02
Effectiveness Date
2017-04-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A a17-2449_1def14a.htm DEF 14A 492943
2 GRAPHIC g24491cai001.gif GRAPHIC 48903
3 GRAPHIC g24491cci001.gif GRAPHIC 66826
4 GRAPHIC g24491bci001.jpg GRAPHIC 16912
5 GRAPHIC g24491cei001.gif GRAPHIC 102745
  Complete submission text file 0001104659-17-027946.txt   818107
Mailing Address 25 BROADWAY, 9TH FLOOR NEW YORK NY 10004
Business Address 25 BROADWAY, 9TH FLOOR NEW YORK NY 10004 212-203-5072
Axsome Therapeutics, Inc. (Filer) CIK: 0001579428 (see all company filings)

IRS No.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37635 | Film No.: 17796281
SIC: 2834 Pharmaceutical Preparations